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Background
Myocardial architectural abnormalities, have been iden-
tified in hypertrophic cardiomyopathy(HCM) gene muta-
tion carriers without hypertrophy(G+LVH-). Some of
these changes may be related to the underlying mutation,
but whether they can predict gene carriage in relatives of
HCM probands is unknown. Cardiac trabeculae may be
prominent in overt HCM, suggesting they could form
part of this constellation of abnormalities but previous
techniques have not permitted more detailed study. We
developed a fractal method for quantitation of trabeculae,
tracked their development in embryonic mice and
applied it to humans imaged by CMR. We hypothesize
that fractal analysis may detect abnormal trabeculae in
HCM mutation carriers before development of LVH and
that a combination of cardiac architectural abnormalities
could be used to predict gene carriage in HCM.
Methods
TRABECULAE IN MOUSE EMBRYONIC DEVELOP-
MENT-63 Murine hearts were examined from the time
of ventricular septation(E14.5) till just before birth
(E18.5). Trabeculae ware charted by fractal analysis of
high-resolution episcopic microscopy images using a
box-counting method. HUMAN MORPHOLOGY-74
G+LVH- sarcomere mutation carriers(29 ± 13 yr[SD]|
51%M) were identified in 12 US-centers(HCMNet|n = 35)
and UCL(n = 39). Subjects underwent CMR and fractal
analysis. Results were compared with 111 overt HCM
patients(G+LVH+|n = 71;G-LVH+|n = 40) and 136
matched controls(36 ± 16 yr|63%M). We analyzed a
single-center(UCL) G+LVH- case-control cohort to iden-
tify factors associated with gene carriage, evaluating
anterior mitral valve leaflets(AMVL), wall thickness,
clefts, trabeculae and other variables. We validated iden-
tified associations in the multi-center HCMNet cohort,
and combined significant parameters into a model for
predicting genetic carriage.
Results
In mice a fractal atlas of trabecular development showed
decreasing complexity across the basal LV(E14.5-18.5;p
< 0.0001) while complexity in the mid/apical LV rose
again just before birth(E17.5-18.5;p < 0.0001|Figure 1).
Contrasting the UCL case-control populations 5 differ-
ences were found and borne out in the validation
cohort. Across the combined HCMNet/UCL cohort
these were:1)longer AMVL(22 ± 3 vs20 ± 3 mm|p <
0.0001), 2)increased maximal-apical trabecular complexity
(1.242 ± 0.07 vs 1.196 ± 0.05|p < 0.0001), 3)increased
maximal-septal systolic wall thickness(13 ± 3 vs 12 ± 2
mm|p = 0.02), 4)lower indexed-end-systolic LV volume
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clefts(35 vs 7%|p < 0.0001). Conditional logistic regression
provided a model containing these parameters, which
predicted gene carriage with a high level of accuracy(78%;
Figure 2).
Conclusions
Fractal analysis applied to microscopy or CMR permits
robust trabecular quantification. Trabecular complexity
is increased in HCM gene mutation carriers even in the
absence of LVH. Myocardial architectural abnormalities
Figure 1 Evolution of cardiac trabeculae in embryonic mice analyzed via fractal analysis of high-resolution (2-3 μm) episcopic
microscopy datasets in complete registration. This atlas of wild-type NIMR:Parkes mice provides the first detailed analyses of quantitative
changes in the anatomical complexity of trabeculae during cardiac morphogenesis. The atlas was compiled from analyses of mice at ages: E14.5,
n = 12; E15.5, n = 14; E16.5, n = 13; E17.5, n = 12 and E18.5, n = 12. Top section: Murine hearts in short axis with insert (bottom left) showing
relative slice location along the LV. Scale bars in millimeters are included for E14.5 and E18.5. Bottom section: Black lines = mean fractal
dimension; Coloured ribbons = 95% confidence intervals. E = embryonic day.
Figure 2 A large population of G+LVH- carriers and matched healthy volunteers underwent detailed morphological assessment by
CMR evaluating anterior mitral valve leaflet (AMVL) length in the 3-chamber view (method described by Maron et al.), diastolic and
systolic wall thicknesses using a 16-segment approach, clefts, trabeculae and other routine CMR parameters. Using conditional logistic
regression and leave-one-out cross validation we developed a predictive model for gene carriership in HCM. By CMR and in this descending
order of power (I to V), the combined presence of: an elongated AMVL (≥20.5 mm); decreased body surface area-indexed left ventricular end-
systolic volume (ESV-i, ≤23.6 mls/m2); increased maximal apical fractal dimension (≥1.279); increased maximal septal systolic wall thickness (SWTs,
≥14.1 mm) and presence of clefts (≥1) predicted gene carriage in this case-control population with a model accuracy of 78%.
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pentad of cardiac architectural abnormalities by CMR
exhibits potential for predicting genetic carriage in HCM.
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